WELLNESS SCORE EVALUATION: 3-Month Progress

Diabetes risk – assesses the likelihood of developing diabetes, using parameters like HbA1c levels, which reflect average blood sugar over the past three months. The risk is categorised as low, medium, or high. Elevated HbA1c levels indicate higher blood sugar, suggesting an increased risk or prescence of diabetes. Lifestyle changes, such as diet and exercise, can help reduce this risk. Regular monitoring and consultation with healthcare professionals are key for effective management.

• On 5 September 2024, the patient had a medium diabetic risk (2/3), indicating potential concerns related to blood sugar regulation. After 24 days on PowerCell PrO Gluco, the diabetic risk decreased to low (1/3) by 29 September 2024. By 2 January 2025, the diabetic risk remained low (1/3), reflecting continued positive trends in glucose metabolism and effective management of diabetes risk.

This progression demonstrates that the patient has made notable improvements in managing stress, recovery, diabetes risk, and hypertension risk, all of which are contributing to better overall health and wellness.

 

Blood Pressure Over Time: Displays the values for blood pressure across the three dates.

Blood pressure is the pressure of circulating blood agains the walls of blood vessels. Normal blood pressure for adlts is defined as a systolic pressure of less than 120 and a diastolic pressure of less than 80. Normal - <120 & <80. Elevated – 120-129 & <80. High Blood Pressure Stage 1 – 130-139 or 80-89. High Blood Pressure Stage 2 - >140 & >90. Hypertensive - >180 &/or >120.

• This graph shows the progression of the patient’s blood pressure across the three assessment dates. On 5 September 2024, the blood pressure was recorded at 114/81 mm Hg, which is slightly elevated for this individual but still within an acceptable range. After 24 days on PowerCell PrO Gluco, the blood pressure improved to 127/84 mm Hg on 29 September 2024, reflecting a response to the treatment. However, by 2 January 2025, the blood pressure slightly decreased to 110/75 mm Hg, which aligns with the patient’s normal range, but the stress experienced prior to this final reading likely contributed to some fluctuation. This highlights the importance of stress management in maintaining optimal blood pressure levels.

Heart Rate Over Time: Shows heart rate changes.

The heart rate (or pulse rate) is the number ot times the hear beats per minute (bpm). Heart rates vary from person to person. Heart rates are lower when at rest and increase during exercise. A normal heart rate for a healthy adult at rest ranges from 60-80 beats per minute. A faster than average heart rate can indicate health problems such as infection, dehydration, stress, anxiety, a thyroid disorder, shock, anemia or certain heart conditions. A lower heart rate is also common for people who exercise frequently and participate in athletics.

• This graph illustrates the changes in the patient’s heart rate across the three assessment dates. On 5 September 2024, the heart rate was measured at 77 bpm, indicating a normal resting heart rate. After 24 days on PowerCell PrO Gluco, the heart rate slightly decreased to 74 bpm on 29 September 2024, suggesting a positive response to the treatment. By 2 January 2025, with the introduction of PowerCell PrO Energy, the heart rate further decreased to 65 bpm, showing continued improvement in the patient’s cardiovascular function and overall health.

Oxygen Saturation Over Time: Tracks the oxygen saturation values.

Oxygen saturation indicates the amount of oxygen in the subject’s blood. The oxygen level is measured as a percentage. Normal values are between 95% - 100%. However, in the presence of some diseases, these ranges may not apply. Your doctor will let you know whats normal fo your specific condition.

• This graph shows the patient's oxygen saturation levels across the three assessment dates. Throughout the assessment period, the oxygen saturation remained consistently at 99%, which is within the normal and healthy range. This stability in oxygen levels indicates that the patient's respiratory function was well-maintained during the treatment period, with no significant changes in oxygen saturation despite the different interventions.

Hemoglobin Over Time: Shows the hemoglobin values.

Hemoglobin is a protein found in red blood cells that plays a crucial role in transporting oxygen from the lungs to the tissues and organs throughout the body. It also helps return carbon dioxide, a waste product of metabolism, from the tissues back to the lungs to be exhaled. Hemoglobin is essential for maintaining the body's oxygen supply and overall cellular function. Hemoglobin levels are typically measured and the result is reported in grams per deciliter (g/dL), with normal ranges varying slightly depending on age, sex, and individual health factors. For adults, normal hemoglobin levels typically fall between:

• Men: 13.8 to 17.2 g/dL
• Women: 12.1 to 15.1 g/dL

Levels outside of the normal range can indicate various health conditions. Low hemoglobin levels (anemia) may suggest issues such as nutritional deficiencies, chronic diseases, or blood loss. High hemoglobin levels can occur due to dehydration, living at high altitudes, or certain lung or heart conditions. Regular monitoring of hemoglobin levels can provide important insights into a person’s health, particularly their ability to transport oxygen effectively throughout the body.

• This graph displays the progression of the patient's hemoglobin levels across three key assessment dates. On 5 September 2024, the hemoglobin level was 12.5 g/dl, reflecting a normal range. By 29 September 2024, the level increased to 13.3 g/dl, suggesting a positive response to the initial treatment. On 2 January 2025, the hemoglobin level slightly decreased to 12.7 g/dl, but remained within a healthy range. This slight fluctuation demonstrates the ongoing stability of the patient’s blood health, indicating effective management and response to the treatment regimen.

Hemoglobin A1C Over Time: Displays the Hemoglobin A1C values.

Hemoglobin A1C (HbA1c) is a form of hemoglobin that is chemically linked to glucose (sugar) in the blood. This process is known as "glycation." The HbA1c test measures the percentage of hemoglobin that has glucose attached to it, which gives an indication of the average blood glucose levels over the past 2-3 months. Unlike a single blood glucose test, which can fluctuate throughout the day, the HbA1c test provides a longer-term view of how well blood sugar levels have been managed. The HbA1c test result is expressed as a percentage, with higher percentages indicating higher levels of glucose in the blood over time. Normal HbA1c levels for non-diabetic adults are typically below 5.7%, while levels between 5.7% and 6.4% are considered prediabetes. An HbA1c level of 6.5% or higher suggests diabetes. For people with diabetes, the goal is usually to maintain an HbA1c level below 7.0% to reduce the risk of complications.

The test is commonly used for:

• Diagnosing diabetes and prediabetes
• Monitoring diabetes management to ensure blood sugar is well-controlled
• Assessing long-term blood glucose control, as it is not influenced by short-term fluctuations in blood sugar levels

Regular monitoring of HbA1c levels is crucial for managing diabetes and preventing long-term complications like heart disease, kidney damage, and nerve damage. It provides a reliable indicator of how well a person is managing their blood glucose over time.

• The patient's Hemoglobin A1C levels show a steady and healthy trend, with values remaining within the normal range over the assessment period. This suggests effective management of blood sugar levels, indicating that the interventions are supporting the patient in maintaining good glucose control. The relatively stable HbA1C values are a positive sign in the context of the patient's overall wellness and health trajectory. 
• NOTE: The patient had a fall (with bruising) and a 3-week duration chest infection in December 2024, just prior to this test. The body uses energy and resources to repair tissue and recover, which can slightly alter blood parameters temporarily.

HRV-SDNN Over Time: Tracks HRV-SDNN values.

HRV-SDNN is a calculated parameter of Heart Rate Variability (HRV). HRV represents the variation in the time interval between heartbeats. SDNN is the standard deviation of the NN intervals, and is used as a leading indicator for HRV measurements.

PNS Index Over Time: Shows PNS Index values.

The parasympathetic nervous system (PNS) is part of the autonomic nervous system, responsible for promoting relaxation and recovery after stress. It helps regulate functions like heart rate, digestion, and respiratory rate by counteracting the effects of the sympathetic nervous system (which triggers the "fight or flight" response). A well-functioning PNS contributes to better stress management, improved recovery, and overall health.

• The patient’s PNS Index shows an improvement over time. On 5 September 2024, the value was -1.0, indicating a lower level of parasympathetic activity and potentially higher stress. By 29 September 2024, the PNS Index rose to 0.6, reflecting a noticeable improvement in parasympathetic function and stress recovery. On 2 January 2025, the PNS Index further improved to 1.6, indicating optimal parasympathetic activity, suggesting that the interventions have successfully enhanced the patient’s ability to relax, recover, and manage stress.

SNS Index Over Time: Tracks SNS Index values.

The sympathetic nervous system (SNS) is responsible for the body’s "fight or flight" response, triggering processes like increased heart rate, heightened alertness, and energy release in response to stress or danger. While essential for reacting to immediate threats, chronic activation of the SNS can lead to stress-related health issues such as hypertension, anxiety, and cardiovascular problems.

• The patient’s SNS Index shows a marked improvement throughout the assessment period. On 5 September 2024, the SNS Index was 1.7, indicating elevated sympathetic activity, likely due to stress. By 29 September 2024, the SNS Index decreased to -0.5, reflecting a reduction in sympathetic dominance and improved stress management. On 2 January 2025, the SNS Index further decreased to -0.8, suggesting that the patient’s stress response has continued to improve, with more balance between the sympathetic and parasympathetic systems. This progression indicates effective treatment and a better capacity to manage stress.

RMSSD Over Time: Shows RMSSD values.

RMSSD (Root Mean Square of Successive Differences) is a measure of heart rate variability that reflects the parasympathetic nervous system's influence on heart rate. It calculates the variation in time between successive heartbeats, with higher values generally indicating better autonomic nervous system function and greater cardiovascular resilience. RMSSD is often used as an indicator of recovery and the body’s ability to adapt to stress.

• The patient's RMSSD values show clear improvement, indicating better autonomic balance and recovery. On 5 September 2024, the RMSSD value was 29 ms, suggesting lower parasympathetic activity and less effective recovery from stress. By 29 September 2024, the RMSSD increased to 53 ms, reflecting improved heart rate variability and better recovery. On 2 January 2025, the value further increased to 84 ms, demonstrating continued enhancement of the patient’s ability to recover and manage stress effectively. This positive trend in RMSSD highlights significant improvements in cardiovascular health and autonomic nervous system regulation.

Mean RRi Over Time: Displays Mean RRi values.

The Mean R-R Interval (RRi) represents the average time interval between successive R-wave peaks on an electrocardiogram (ECG), which corresponds to heartbeats. It is commonly used as an indicator of heart rate variability, with longer intervals typically indicating a slower heart rate and greater parasympathetic activity, which is associated with relaxation and recovery.

• The patient's Mean RRi values show positive improvement over time. On 5 September 2024, the Mean RRi was 775 ms, which is within a normal range but indicates less parasympathetic activity and greater sympathetic dominance. By 29 September 2024, the Mean RRi increased to 980 ms, reflecting improved cardiovascular function and greater relaxation. On 2 January 2025, the Mean RRi slightly decreased to 928 ms, but still remains within a healthy range, indicating sustained autonomic balance and continued improvement in the patient’s heart rate variability and recovery. This progression demonstrates effective management of stress and enhancement of overall heart health,

PRQ Over Time: Tracks the PRQ values.

The Pulse-Respiration Quotient (PRQ) is the ratio of pulse rate (beats per minute) to respiratory rate (breaths per minute), reflecting how efficiently the heart and lungs work together. The normal PRQ is around 5, with a pulse of 60bpm corresponding to 12 rpm and 100 bpm to 20 rpm. Significant deviations may indicate inefficient heart or lung gunction, suggesting the need to consult a physician. Abnormal PRQ readings can also indicate pathophysiological states related to disease or injury. The PRQ is a measure of an individual's resilience, reflecting their capacity to cope with stress and recover from challenges. Higher PRQ values generally indicate better mental and physical resilience, which is associated with improved well-being and the ability to manage stress effectively.

• The patient's PRQ values indicate a positive trend in their resilience. On 5 September 2024, the PRQ was recorded at 4.0, reflecting a normal level of resilience but room for improvement. By 29 September 2024, the PRQ maintained at 4.0, indicating stability in the patient's stress coping ability. However, by 2 January 2025, the PRQ rose to 4.7, suggesting an improvement in the patient's resilience and overall mental and physical well-being. This upward trend reflects the positive effects of the treatments and interventions, helping the patient enhance their ability to manage stress and maintain a balanced state of health.

Breathing Rate Over Time: Shows the breathing rate.

Breathing Rate is the number of breaths taken per minute (Respirations per Minute, RPM) of the subject. The normal respiration rate for an adult at rest is 12-20 breaths per minute. A respiration ratue under 12 or over 25 breaths per minute while resting is considered abnormal. Children have faster respiratory rates than adults, and the normal respiratory rate can ve\ary significantly by age. The respiratory rate should be measured when a person is at rest and has not engaged in vigorous activity. In general, respiratrory rates are slightly faster in women than men.

These graphs display the changes across the three dates and help highlight the progression in each aspect of health.